AKL-T01: Clinical Trials

2 trials of AKL-T01, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow AKL-T01: new trials by email Literature Review of AKL-T01 trials Research Report on AKL-T01

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Digital Intervention for Post-Stroke Depression and Executive Dysfunction
AKL-T01, Metacognitive Strategy Training - Executive Dysfunction, Depression
Phase 2RecruitingWeill Medical College of Cornell University702023-03-012026-08-20
Improving Cognitive Health in COVID-19 Survivors
AKL-T01 - Cognitive Dysfunction, Covid19
Phase 2CompletedWeill Medical College of Cornell University1102021-07-132024-02-29

Conditions studied

COVID-19 (1)  ·  Cognitive Dysfunction (1)  ·  Depression (1)  ·  Stroke (1)

Sponsors

Weill Medical College of Cornell University (2)

Countries

United States (2)

Top investigators

Abhishek Jaywant, PhD (1)  ·  Faith Gunning, PhD (1)

NIH funding

K23MH129849 (1)